| muscular invasive bladder cancer (MIBC) | ||
| MIBC - NA - all population | MIBC - NA - PDL1 positive | |
| immune chekpoint inhibitors | ||
| anti-PD-(L)1 | ||
| atezolizumab based treatment | ||
| atezolizumab alone | IMvigor-010 | |
| nivolumab based treatment | ||
| nivolumab alone | CheckMate 274 ... | CheckMate 274 ... |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
